An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid
- PMID: 12804106
- DOI: 10.1089/105072503321669875
An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid
Abstract
The recent prevalence of ultrasound-guided fine-needle aspiration biopsy has resulted in a marked increase in the number of patients with papillary microcarcinoma (maximum diameter, </= 10 mm) of the thyroid detected by this sophisticated tool. On the other hand, it is debatable whether patients with papillary microcarcinoma should always undergo surgery after diagnosis, because a high incidence of occult papillary carcinoma has been observed in autopsy studies. Thus, we proposed observation without surgical therapy as a treatment option in 732 patients diagnosed with papillary microcarcinoma by the above technique from 1993 to 2001. One hundred sixty-two patients chose observation and were classified as the observation group. During the follow-up period for patients in the observation group, more than 70% of tumors either did not change or decreased in size compared to their initial size at diagnosis. They enlarged by more than 10 mm in 10.2%, and lymph node metastasis in the lateral compartments appeared in only 1.2% of patients during follow-up. On the other hand, 570 patients chose surgical treatment at diagnosis and 56 patients in the observation group who underwent surgery after a period of follow-up were classified as the surgical treatment group. Of these 626 patients, lymph node dissection was performed in 594 patients, and metastasis was confirmed histologically in 50.5%. Multiple tumor formation was seen in 42.8% of patients. In this group, the rate of recurrence was 2.7% at 5 years and 5.0% at 8 years after surgery. Our preliminary data suggest that papillary microcarcinomas do not frequently become clinically apparent, and that patients can choose observation while their tumors are not progressing, although they are pathologically multifocal and involve lymph nodes in high incidence.
Similar articles
-
Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.Minerva Endocrinol. 2013 Sep;38(3):269-79. Minerva Endocrinol. 2013. PMID: 24126547
-
Papillary microcarcinoma of the thyroid: how should it be treated?World J Surg. 2004 Nov;28(11):1115-21. doi: 10.1007/s00268-004-7644-5. World J Surg. 2004. PMID: 15490053
-
[Non-incidental papillary microcarcinomas of the thyroid].Medicina (B Aires). 2008;68(2):139-43. Medicina (B Aires). 2008. PMID: 18499963 Spanish.
-
[Thyroid microcarcinoma].Nihon Rinsho. 1996 May;54(5):1354-8. Nihon Rinsho. 1996. PMID: 8965365 Review. Japanese.
-
A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid.Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):240-8. doi: 10.1038/ncpendmet0428. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17315032 Review.
Cited by
-
Risk nomogram for papillary thyroid microcarcinoma with central lymph node metastasis and postoperative thyroid function follow-up.Front Endocrinol (Lausanne). 2024 Oct 28;15:1395900. doi: 10.3389/fendo.2024.1395900. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39530115 Free PMC article.
-
Standardized Ultrasound Evaluation for Active Surveillance of Low-Risk Thyroid Microcarcinoma in Adults: 2024 Korean Society of Thyroid Radiology Consensus Statement.Korean J Radiol. 2024 Nov;25(11):942-958. doi: 10.3348/kjr.2024.0871. Korean J Radiol. 2024. PMID: 39473087 Free PMC article.
-
Active surveillance of papillary thyroid carcinoma in Latin America: a scoping review.Arch Endocrinol Metab. 2024 Sep 24;68:e230495. doi: 10.20945/2359-4292-2023-0495. eCollection 2024. Arch Endocrinol Metab. 2024. PMID: 39420943 Free PMC article. Review.
-
Rethinking the prognosis model of differentiated thyroid carcinoma.Front Endocrinol (Lausanne). 2024 Sep 30;15:1419125. doi: 10.3389/fendo.2024.1419125. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39403579 Free PMC article.
-
A nomogram for enhanced risk stratification for predicting cervical lymph node metastasis in papillary thyroid carcinoma patients.Discov Oncol. 2024 Sep 27;15(1):476. doi: 10.1007/s12672-024-01370-w. Discov Oncol. 2024. PMID: 39331286 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
